You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: May 2, 2024

~ Buy the QBREXZA (glycopyrronium tosylate) Drug Profile, 2024 PDF Report in the Report Store ~

CLINICAL TRIALS PROFILE FOR QBREXZA

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for QBREXZA

Subscribe to access the full database, or Try a Trial
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT04159610 ↗	Assessment of Safety, Tolerability and Efficacy of 1% GPB Cream Versus Qbrexza® (Glycopyrronium) Cloth 2.4% Under Maximum-Use Conditions in Subjects With Primary Axillary Hyperhidrosis	Not yet recruiting	Therapeutics, Inc.	Phase 2	2022-07-01	The aim of this study is to investigate the safety, tolerability and efficacy of 1% GPB Cream compared to Qbrexza® (glycopyrronium) cloth, 2.4%, for topical use under maximum use conditions.
NCT04159610 ↗	Assessment of Safety, Tolerability and Efficacy of 1% GPB Cream Versus Qbrexza® (Glycopyrronium) Cloth 2.4% Under Maximum-Use Conditions in Subjects With Primary Axillary Hyperhidrosis	Not yet recruiting	Dr. August Wolff GmbH & Co. KG Arzneimittel	Phase 2	2022-07-01	The aim of this study is to investigate the safety, tolerability and efficacy of 1% GPB Cream compared to Qbrexza® (glycopyrronium) cloth, 2.4%, for topical use under maximum use conditions.
NCT04906655 ↗	An Open Label Study for Palmar Hyperhydrosis	Completed	Virginia Clinical Research, Inc.	Phase 2	2020-10-01	The purpose of this open-label study is to evaluate the efficacy and safety of different methods of application of glycopyrronium cloth, 2.4% in patients with palmar hyperhidrosis
NCT04906655 ↗	An Open Label Study for Palmar Hyperhydrosis	Completed	Pariser, Robert J., M.D.	Phase 2	2020-10-01	The purpose of this open-label study is to evaluate the efficacy and safety of different methods of application of glycopyrronium cloth, 2.4% in patients with palmar hyperhidrosis
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for QBREXZA

Condition Name

Chart
Table

Condition Name for QBREXZA
Intervention	Trials
Hyperhidrosis	2
Palmar Hyperhidrosis	1
Primary Axillary Hyperhidrosis	1
Skin Diseases	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for QBREXZA
Intervention	Trials
Hyperhidrosis	3
Sweat Gland Diseases	1
Skin Diseases	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for QBREXZA

Trials by Country

Map
Table

Trials by Country for QBREXZA
Location	Trials
United States	2
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for QBREXZA
Location	Trials
Utah	1
Virginia	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for QBREXZA

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for QBREXZA
Clinical Trial Phase	Trials
Phase 2	3
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for QBREXZA
Clinical Trial Phase	Trials
Completed	1
Not yet recruiting	1
Recruiting	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for QBREXZA

Sponsor Name

Chart
Table

Sponsor Name for QBREXZA
Sponsor	Trials
Therapeutics, Inc.	1
Dr. August Wolff GmbH & Co. KG Arzneimittel	1
Virginia Clinical Research, Inc.	1
[disabled in preview]	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for QBREXZA
Sponsor	Trials
Other	3
Industry	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.